Continued safety and long-term effectiveness of onasemnogene abeparvovec in Ohio (Waldrop MA, Chagat S, Storey M, Meyer A, Iammarino M, Reash N, Alfano L, Lowes L, Noritz G, Prochoroff A, Rossman I, Ginsberg M, Mosher K, Broomall E, Bass N, Gushue C, Kotha K, Paul G, Shell R, Tsao CY, Mendell JR, Connolly AM) Neuromuscular Disorders January 2024;34:41-48 SCOPUS ID: 2-s2.0-85180576734 01/01/2024 15 Citations